LN Pill - pink capsule/oblong, 11mm
Generic Name: fludarabine
Pill with imprint LN is Pink, Capsule/Oblong and has been identified as Oforta fludarabine phosphate 10 mg. It is supplied by Sanofi-Aventis.
Oforta is used in the treatment of Chronic Lymphocytic Leukemia; Non-Hodgkin's Lymphoma; Leukemia and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Oforta fludarabine phosphate 10 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for LN
Oforta
- Generic Name
- fludarabine
- Imprint
- LN
- Strength
- fludarabine phosphate 10 mg
- Color
- Pink
- Size
- 11.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Antimetabolites
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sanofi-Aventis
- National Drug Code (NDC)
- 00024-5820 (Discontinued)
- Inactive Ingredients
-
microcrystalline cellulose,
lactose monohydrate,
silicon dioxide,
croscarmellose sodium,
magnesium stearate,
hypromelloses,
magnesium silicate,
titanium dioxide,
ferric oxide red,
ferric oxide yellow
Note: Inactive ingredients may vary.
Related images for "LN"
More about Oforta (fludarabine)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antimetabolites
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
